A single arm phase II study of the efficacy of tamoxifen in triple negative (oestrogen receptor alpha negative, progesterone receptor negative, HER-2 negative) but oestrogen receptor beta positive metastatic breast cancer (ANZ 1001 SORBET)
收藏Research Data Australia2024-08-03 收录
下载链接：
https://researchdata.edu.au/a-single-arm-1001-sorbet/2538189
下载链接
链接失效反馈官方服务：
资源简介：
Dataset of 5 women with metastatic breast cancer that is ERβ positive but ERα negative, PgR negative and HER-2 negative (triple negative breast cancer). Participants received tamoxifen 20mg daily. The primary objective was to assess the efficacy of tamoxifen in triple negative(oestrogen receptor alpha negative, progesterone receptor negative, HER-2 negative) but oestrogen receptor beta positive metastatic breast cancer.
提供机构：
Health Data Australia Contributor Records
